Immediate Impact
48 standout
Citing Papers
Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews
2023 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of G Mignot being referenced
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| G Mignot | 25 | 73 | 32 | 334 | 107 | 15 | 412 | |
| F. Cañas | 20 | 48 | 22 | 312 | 93 | 25 | 429 | |
| Ralph Aquila | 9 | 76 | 26 | 351 | 111 | 14 | 425 | |
| Shubhra Mace | 13 | 123 | 36 | 273 | 92 | 14 | 459 | |
| W. Chrzanowski | 10 | 117 | 44 | 398 | 95 | 11 | 481 | |
| Fuminari Misawa | 9 | 89 | 27 | 405 | 89 | 27 | 460 | |
| Eun Kee Chung | 6 | 74 | 23 | 326 | 100 | 14 | 427 | |
| Ellen M. Weissman | 45 | 38 | 37 | 265 | 80 | 19 | 485 | |
| Mark D. Watanabe | 15 | 58 | 41 | 247 | 82 | 10 | 400 | |
| Fernando Cañas | 42 | 31 | 25 | 301 | 118 | 29 | 459 | |
| H. A. McClelland | 36 | 67 | 26 | 299 | 67 | 25 | 510 |
All Works
Loading papers...